Spots Global Cancer Trial Database for Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
Official Title: Multinational European Trial for Children With the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome
Study ID: NCT01868269
Study Description
Brief Summary: The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (European Paediatric Neurology Society), the GPOH (Gesellschaft für Pädiatrische Hematologic und Oncologie) and the SIOPEN (SIOP (International Society Oncology Pediatric) Europe Neuroblastoma). This protocol will investigate an escalating treatment schedule starting with a corticosteroid standard treatment with dexamethasone pulses (first step), which is followed, if response has been inadequate after 3 months of treatment, by the addition of CP (second step) and, if still no sufficient improvement, by the replacement of CP by Rituximab (third step). Treatment intensification is decided on the basis of standardized scoring of OMS/DES severity.
Detailed Description:
Keywords
Eligibility
Minimum Age: 6 Months
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE, Wien, , Austria
Chu de Bicetre, Le Kremlin-Bicêtre, LE Kremlin Bicetre, France
Centre Oscar Lambret, Lille, Lille Cedex, France
Centre Leon Berard, Lyon, LYON Cedex 08, France
Hopita D'Enfants de La Timone, Marseille, Marseille Cedex 5, France
Hopital Arnaud de Villeneuve, Montpellier, Montpellier Cedex 4, France
Chr de Nantes, Nantes, Nantes Cedex01, France
Chu de Nice Archet 2, Nice, NICE Cedex 03, France
Ch Trousseau, Paris, Paris Cedex 12, France
Chu Hopital Sud, Rennes, Rennes Cedex 02, France
Chu de Rouen, Rouen, Rouen Cedex, France
CHU DE STRASBOURG HOPITAL Hautepierre, Strasbourg, Strasbourg Cedex, France
Chu Toulouse Hopital Des Enfants, Toulouse, Toulouse Cedex 9, France
Chu Amiens, Amiens, , France
Chu Angers, Angers, , France
Hopital Jean Minjoz, Besancon, , France
Chr Pellegrin, Bordeaux, , France
CHU CAEN, Caen, , France
Chu D'Estaing, Clermont Ferrand, , France
Chu Dijon, Dijon, , France
Chu de Grenoble, Grenoble, , France
Chu de Limoges, Limoges, , France
Institut Curie, Paris, , France
Chu de Poitiers, Poitiers, , France
Chu de Reims, Reims, , France
CHU LA REUNION Site Félix Guyon, Saint-denis, , France
Chu Saint Etienne, Saint-Étienne, , France
Chu Tours Hopital Clocheville, Tours, , France
Hopital Nancy Brabois, Vandoeuvre Les Nancy, , France
Institut de Cancerologie Gustave Roussy, Villejuif, , France
G. Gaslini Institut, Genova, , Italy
The Fundación para la Formación e Investigación Sanitarias de la Región de Murcia, El Palmar, , Spain
University Hospital Lund, Lund, , Sweden
Universitätskinderklinik, Bern, , Switzerland
Kinderspital Zurich, Zurich, , Switzerland
John Radcliffe Hospital, Oxford, , United Kingdom
Contact Details
Name: Gudrun Schleiermacher, MD
Affiliation: Institut Curie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
